PERTILE, Paolo
PERTILE, Paolo
DIPARTIMENTO DI SCIENZE ECONOMICHE
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response
2015-01-01 Chick, Stephen; Forster, Martin; Pertile, Paolo
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response
2017-01-01 Chick, Stephen; Forster, Martin; Pertile, Paolo
A large scale OLG model for France, Italy and Sweden: assessing the interpersonal and intrapersonal redistributive effects of public policies
2014-01-01 Bucciol, Alessandro; Cavalli, Laura; Fedotenkov, I.; Pertile, Paolo; Polin, Veronica; Sartor, Nicola; Sommacal, Alessandro
A Large Scale OLG Model for the Analysis of the Redistributive Effects of Policy Reforms
2017-01-01 Bucciol, Alessandro; Cavalli, Laura; Fedotenkov, Igor; Pertile, Paolo; Polin, Veronica; Sartor, Nicola; Sommacal, Alessandro
A reply to "Who would benefit from average value-based pricing?"
2021-01-01 Levaggi, Rosella; Pertile, Paolo
An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography
2009-01-01 Pertile, Paolo
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition"
2020-01-01 Levaggi, Rosella; Pertile, Paolo
Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial
2021-01-01 Forster, Martin; Brealey, Stephen; Chick, Stephen; Keding, Ada; Corbacho, Belen; Alban, Andres; Pertile, Paolo; Rangan, Amar
DRGs: the link between investment in technologies and appropriateness. WP Series University of Verona Department of Economics (ISSN 2036-2919), 31/2012
2012-01-01 Levaggi, Rosella; Moretto, Michele; Pertile, Paolo
Drug Prices and Incentives to Innovation by the Pharmaceutical Industry
2015-01-01 R., Levaggi; Pertile, Paolo
Dynamic, economic approaches to HTA under uncertainty. WP Series University of Verona Department of Economics (ISSN 2036-2919), 03/2011
2011-01-01 Forster, M.; Pertile, Paolo
Efficienza e sostenibilità dell’intervento pubblico
2022-01-01 Greco, Luciano; Pertile, Paolo; Zoli, Claudio
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence
2018-01-01 Pertile, Paolo; Gamba, Simona; Forster, Martin
Investimenti pubblici, risorse scarse: il ruolo dei diversi metodi di supporto alle decisioni
2022-01-01 Pertile, P.; Cisco, G.
Investment in health technologies in a competitive model with real options
2008-01-01 Pertile, Paolo
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy
2015-01-01 Pertile, Paolo; Poli, Albino; Dominioni, Lorenzo; Rotolo, Nicola; Nardecchia, Elisa; Castiglioni, Massimo; Paolucci, Massimo; Mantovani, William; Imperatori, Andrea
Job Sick Leave: Detecting Opportunistic Behavior
2019-01-01 Biscardo, CARLO ALBERTO; Bucciol, Alessandro; Pertile, Paolo
L'ISEE in Italia: una nota metodologica partendo dai dati EU-SILC. University of Verona Department of Economics Working Paper 6/2014 (ISSN 2036-2919)
2014-01-01 Bucciol, Alessandro; Cavalli, Laura; Dalla Chiara, E.; Menon, Martina; Pertile, Paolo; Sommacal, Alessandro
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation
2015-01-01 Jobjornsson, Sebastian; Forster, Martin; Pertile, Paolo; Burman, Carl Fredrik
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation
2016-01-01 Jobjörnsson, Sebastian; Forster, Martin; Pertile, Paolo; Burman, Carl Fredrik